­

About peptomyc_2015

This author has not yet filled in any details.
So far peptomyc_2015 has created 11 blog entries.

Peptomyc receives 212000 euros from the Spanish Centre for the Development of Industrial Technology (CDTI)

 

This latest award from the CDTI and Spanish Ministry Mineco represents substantial further support for Peptomyc’s mission and will help in the development of OMO-101 and its derivative OMO-103. The project is titled “Pre-clinical development of Myc-inhibiting peptides to treat cancer” (“Desarrollo pre-clínico de péptidos inhibidores de Myc para el tratamiento de cáncer”).

 

The award is from […]

03 / 05 / 17|

Peptomyc receives further support from Spanish Ministry Mineco

 

In their latest successful application for funding, Peptomyc has earned 15000 euros from the CDTI in the Spanish Ministry of Economy, Industry and Competitiveness (Mineco). APC grants (Ayudas a la Preparación de Propuestas Comunitarias) are designed to promote the participation of Spanish companies in 3 specific Calls for research and innovation that are financed by […]

25 / 04 / 17|

Peptomyc wins Startup Slam competition at BIO-Europe Spring® Barcelona

Neruda Scott (Johnson & Johnson), Bauke Anninga (Innovation Forum), Laura Soucek (Peptomyc) and Emma Kohring (Johnson & Johnson).

 

Panel of expert judges selects winner from 14 short-listed European start-ups that showed greatest potential for transformative healthcare solutions

Startup Slam sponsor and co-host Johnson & Johnson Innovation recognizes high caliber of entries selected to compete for prestigious award

[…]

25 / 03 / 17|

Peptomyc is proud to join CatalonioBio

 

CataloniaBio is an association of companies in the health and life sciences arena in Catalonia. Its mission is to represent and support companies interested in promoting a strategic, innovative cluster, as well as helping to define the framework for sector-wide actions and industrial policies established at a national and European level.

The association was created in 2006 by a group of entrepreneurs […]

24 / 03 / 17|

Peptomyc receives 850K € from Spanish Mineco and European Commission joint fund

 

The project is financed by the Spanish Ministry of Economy and Competition (Ministerio de Economía y Competitividad), and co-financed by the European Regional Development Fund (ERDF; known as FEDER in Spain). It corresponds to the 2016 Challenge-Collaboration (Retos-Colaboración) call of the Programa Estatal de Investigación, Desarrollo e Innovación Orientada a los Retos de la Sociedad, […]

30 / 11 / 16|

Peptomyc wins prize at EIT Health Summit

 
Barcelona 23-24th November 2016
Around 350 participants from 19 countries joined the EIT Health Summit on 23 and 24 November 2016 in Barcelona. During the meeting, participants enjoyed networking opportunities and the chance to learn more about EIT Health activities and involvement opportunities.

A highlight of the event was the Business Plan Aggregator Competition. 21 start-ups pitched their […]

23 / 11 / 16|

Peptomyc completed a successful and constructive Briefing Meeting with the Innovation Task Force of the European Medicines Agency (EMA) at their headquarters in London, U.K.

 
Such Briefing Meetings provide a forum for early dialogue covering regulatory, technical and scientific issues arising from the development of innovative medicines. The scientific informal brainstorming discussions are led by experts from the Agency network, working parties and committees, and complement and reinforce existing formal procedures.

19 / 09 / 16|

Peptomyc completes Seed Funding of €1M

Funds will help company reach preclinical validation for lead candidate in glioblastoma – an aggressive and lethal brain tumor – and in other cancer indications.

[…]

27 / 04 / 16|

Peptomyc receives a business grant from ACCIÓ

 
This second grant in 2 months further supports Peptomyc in its mission to bring novel Myc inhibitors closer to clinical use for cancer treatment.

[…]

22 / 03 / 16|

Peptomyc succeeds in gaining first grant funding from the European Commission

This grant represents the first big step forward for the company as it looks for further funding from investors to bring its novel Myc inhibitors closer to clinical application in cancer.

[…]

22 / 02 / 16|